Brief: Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results And Clinical Progress
12/05/2026 22:29
May 12 (Reuters) - Zentalis Pharmaceuticals Inc ZNTL.O: ZENTALIS PHARMACEUTICALS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND CLINICAL PROGRESS Source text: ID:nGNX5MmTmY Further company coverage: ZNTL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer